http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104174013-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8c1e1715862a231c3450fbfb046bd1f8
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-522
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-616
filingDate 2014-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2015-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90d3346ea1ba9f5e6eb6c43f4cc011ed
publicationDate 2015-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-104174013-B
titleOfInvention Composition containing hepatocyte growth-promoting factors and application thereof
abstract The invention discloses a composition containing hepatocyte growth-promoting factors and application thereof. According to the formula, the composition containing hepatocyte growth-promoting factors is prepared from the following raw materials in parts by weight: 8-10 parts of hepatocyte growth-promoting factors, 5-7 parts of aspirin, 2-3 parts of acyclovir and 1.5-2.5 parts of folic acid. According to the composition containing hepatocyte growth-promoting factors, aspirin, acyclovir and folic acid are introduced in research of medicines for treating severe hepatitis for the first time; the hepatocyte growth-promoting factors, aspirin, acyclovir and folic acid are mixed, so that a very good treatment effect on the severe hepatitis is achieved.
priorityDate 2014-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID282879
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP14210
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID24446
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419552576
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3082
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID395941
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9BH09
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ76BS1
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398513
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID15234
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID493781
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555458
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID403441
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID463503
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398658
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ867B7
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP17945
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556224
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ08048

Total number of triples: 37.